Oxbridge Biotech Roundtable

A London-based startup tackling Parkinson’s with new medicines to prevent neurodegeneration and a Utah-based company with a surgical device to allow complete healing of ligament and tendon injuries have each won £100k/$150k non-dilutive funding.